2016
DOI: 10.1016/j.eururo.2016.02.046
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular Vesicles and Their Role in Urologic Malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
71
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 86 publications
(71 citation statements)
references
References 72 publications
0
71
0
Order By: Relevance
“…The biogenesis and release of Exos is a complex symphony involving a series of factors, representatively including the endosomal sorting complexes required for transport (ESCRT), ALIX (also known as programed cell death 6‐interacting protein), phospholipase, vacuolar protein sorting‐associated 4 (VPS4), Rab GTPase proteins, sphingomyelinase, and ceramide 57, 58, 59…”
Section: Biogenesis and Release Of Evsmentioning
confidence: 99%
“…The biogenesis and release of Exos is a complex symphony involving a series of factors, representatively including the endosomal sorting complexes required for transport (ESCRT), ALIX (also known as programed cell death 6‐interacting protein), phospholipase, vacuolar protein sorting‐associated 4 (VPS4), Rab GTPase proteins, sphingomyelinase, and ceramide 57, 58, 59…”
Section: Biogenesis and Release Of Evsmentioning
confidence: 99%
“…It was identified that miR-19a is cardioprotective, miR22 improve ischaemic injury and reduce apoptosis and 20S proteasome promote angiogenesis and inhibit oxidative stress [14] . Interestingly, it was found that the exchange of mRNA, miRNA and proteins may be bidirectional, MVs released from injured cells may reprogram the phenotype of stem cells to induce differentiation.…”
Section: Surface Markersmentioning
confidence: 99%
“…. The MVB fuses with the plasma membrane to release the contained exosomes in the extracellular space.MVB = multivesicular body [14] . Alix ALG-2-interacting protein X, MHC major histocompatibility complex, miRNA microRNA, Tsg101 tumour susceptibility gene 101, MVB multivesicular body (7).…”
Section: Challengesmentioning
confidence: 99%
“…[2][3][4][5][6] In this Review we provide an update on the use of miRNAs specifically within the blood and/or urine of patients with urological cancers as diagnostic, prognostic and predictive biomarkers.…”
mentioning
confidence: 99%
“…23 The precise function of secreted vesicles is still under discussion, but results show that miRNAs enable cells to communicate with each other. 6,18,19 Detecting miRNAs in biofluids is challenging and methodological pitfalls have to be taken into account. Factors that could affect miRNA measurements in the preanalytical, analytical and postanalytical phases of detection include the method of sample collection, processing conditions, storage conditions, RNA isolation technique, quality control, quantification principle and the method of data evaluation (Box 1).…”
mentioning
confidence: 99%